Apple's logo, one of the most recognizable symbols worldwide, is lauded for its simplicity and the intriguing theories about ...

The bitten apple is a real icon of the company led by Tim Cook. However, the image of this company was not always so. The first logo had the image of Isaac Newton and was designed, in 1976 ...

Experts at LOGO.com have theorised the bite taken out of the apple may not just be a nod to the company's name, but it could also be a reference to the biblical story of Adam and Eve. The bite ...

An insider says some suppliers will benefit from increased iPhone sales in 2025, fueled by the iPhone 17 Air and Apple ...

Clearly there are a lot of people who love working in pharma and biotech — but why? Biotech companies have plenty of perks, sometimes including top-tier benefits like sabbaticals, unlimited ...

Here are some of the top performing biotech stocks. Many, or all, of the products featured on this page are from our advertising partners who compensate us when you take certain actions on our ...

Cell therapy biotech Tolerance Bio has unveiled with $17.2 million and a mission of targeting immune diseases by stretching and saving the function of a key organ. The Philadelphia biotech’s ...

Biotech company Illumina last year said it would divest diagnostic test maker Grail after heated battles with the FTC and ...

Allison DeAngelis, who covers biotech startups and venture capital, is also the author of STAT’s annual report “Ranking Biotech’s Top Venture Capital Firms.” Biotech investors have been ...

Legend Biotech (LEGN) announced the appointment of Alan Bash as the Company’s President of CARVYKTI. In this newly created role, Mr. Bash will be responsible for managing the continued growth of ...

The biotech industry is one of the top for attracting VC money, and some say it's recession-proof. Whether you're interested in agriculture, pharmacy, medicine, or bioengineering, there are ...

Genscript Biotech (HK:1548) has released an update. Genscript Biotech’s associate, Legend Biotech, is making strides in the treatment of multiple myeloma, providing promising data from the Phase ...